Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

February 01, 2017; Volume 91,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aa, Jiye

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  2. Aa, Nan

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  3. Akk, Gustav

    1. You have access
      The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484

B

  1. Bass, Caroline E.

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638
  2. Bhatt, Tanya

    1. You have access
      Dynamin Functions and Ligands: Classical Mechanisms Behind
      Mahaveer Singh, Hemant R. Jadhav and Tanya Bhatt
      Molecular Pharmacology February 2017, 91 (2) 123-134; DOI: https://doi.org/10.1124/mol.116.105064
  3. Blume, Lawrence C.

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638
  4. Bosnyak, Sanja

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153
  5. Brady, Ryan

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

C

  1. Campbell, Adrian P.

    1. You have access
      Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors
      Adrian P. Campbell, Laurence P. G. Wakelin, William A. Denny and Angela M. Finch
      Molecular Pharmacology February 2017, 91 (2) 135-144; DOI: https://doi.org/10.1124/mol.116.105874
  2. Cao, Bei

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  3. Charman, William N.

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153
  4. Chen, Qiang

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  5. Christopoulos, Arthur

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153
  6. Cook, Anna E.

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

D

  1. Denny, William A.

    1. You have access
      Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors
      Adrian P. Campbell, Laurence P. G. Wakelin, William A. Denny and Angela M. Finch
      Molecular Pharmacology February 2017, 91 (2) 135-144; DOI: https://doi.org/10.1124/mol.116.105874
  2. Diepenhorst, Natalie A.

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

E

  1. Eldeeb, Khalil

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

F

  1. Fei, Fei

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  2. Feng, Dong

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  3. Feng, Siqi

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  4. Finch, Angela M.

    1. You have access
      Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors
      Adrian P. Campbell, Laurence P. G. Wakelin, William A. Denny and Angela M. Finch
      Molecular Pharmacology February 2017, 91 (2) 135-144; DOI: https://doi.org/10.1124/mol.116.105874

G

  1. Ge, Chun

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  2. Germann, Allison L.

    1. You have access
      The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484
  3. Guo, Grace L.

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  4. Guo, Jiahua

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

H

  1. Hantgan, Roy R.

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638
  2. He, Jun

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  3. Howlett, A­llyn C.

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638
  4. Huang, Jingqiu

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

I

  1. Ilyasov, Alexander A.

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

J

  1. Jadhav, Hemant R.

    1. You have access
      Dynamin Functions and Ligands: Classical Mechanisms Behind
      Mahaveer Singh, Hemant R. Jadhav and Tanya Bhatt
      Molecular Pharmacology February 2017, 91 (2) 123-134; DOI: https://doi.org/10.1124/mol.116.105064
  2. Jin, Xiaochun

    1. You have access
      The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484
  3. Johnson, Jeffrey R.

    1. You have access
      G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

K

  1. Keegan, Bradley M.

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638
  2. Kong, Bo

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  3. Krogan, Nevan J.

    1. You have access
      G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

L

  1. Langmead, Christopher J.

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153
  2. Leone-Kabler, Sandra

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638
  3. Lowther, W. Todd

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

M

  1. Mannoury la Cour, Clotilde

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153
  2. McCollum, Megan M.

    1. You have access
      The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484
  3. Mocaer, Elisabeth

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

N

  1. Newton, Billy W.

    1. You have access
      G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

O

  1. O’Neal, Jeremy E.

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

P

  1. Pan, Yang

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  2. Patten, Theresa

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

R

  1. Riddy, Darren M.

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153
  2. Riordan, Daniel P.

    1. You have access
      G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

S

  1. Schumacher, Justin D.

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  2. Selley, Dana E.

    1. You have access
      Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638
  3. Sexton, Patrick M.

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153
  4. Shen, Jianliang

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  5. Singh, Mahaveer

    1. You have access
      Dynamin Functions and Ligands: Classical Mechanisms Behind
      Mahaveer Singh, Hemant R. Jadhav and Tanya Bhatt
      Molecular Pharmacology February 2017, 91 (2) 123-134; DOI: https://doi.org/10.1124/mol.116.105064
  6. Steinbach, Joe Henry

    1. You have access
      The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484
  7. Summers, Roger J.

    1. You have access
      Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153
  8. Sun, Runbin

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  9. Sundaram, Aparna B.

    1. You have access
      G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

T

  1. Trester-Zedlitz, Michelle

    1. You have access
      G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369
  2. Tsvetanova, Nikoleta G.

    1. You have access
      G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

V

  1. von Zastrow, Mark

    1. You have access
      G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

W

  1. Wakelin, Laurence P. G.

    1. You have access
      Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors
      Adrian P. Campbell, Laurence P. G. Wakelin, William A. Denny and Angela M. Finch
      Molecular Pharmacology February 2017, 91 (2) 135-144; DOI: https://doi.org/10.1124/mol.116.105874
  2. Wang, Guangji

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  3. Wang, Pei

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

Y

  1. Yang, Chung S.

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  2. Yang, Na

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
  3. Yu, Xiaoyi

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      You have access
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 91 (2)
Molecular Pharmacology
Vol. 91, Issue 2
1 Feb 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics